[Paradoxical response of adrenal glands to dexamethasone in a case of adrenal carcinoma].
D015065:17-Hydroxycorticosteroids / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000310:Adrenal Gland Neoplasms / Q000175:diagnosis / Q000378:metabolism*; D000311:Adrenal Glands / Q000187:drug effects*; D000324:Adrenocorticotropic Hormone; D000328:Adult; D002277:Carcinoma / Q000175:diagnosis / Q000378:metabolism; D003480:Cushing Syndrome / Q000175:diagnosis; D003907:Dexamethasone / Q000494:pharmacology*; D005260:Female; D006801:Humans; D008797:Metyrapone; D010690:Phlebography; D012188:Retropneumoperitoneum
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone; D008797:Metyrapone
Paradoxes Ansprechen der Nebenniere auf Dexamethason bei einem Nebennierenkarzinom